Evidence map›Paper›PMID 42193370›Full record

ReviewBiomedicines2026

Therapeutic Potential of Probiotics in the Modulation of Antibiotic Resistance in

Lazzat Zhussupbekova, Alina Bulatova, Dinara Nurkina, Klara Kurmangaliyeva, Venera Rakhmetova, Aigyul Izhanova, Kaergeldy Makhambetov, Elmira Akhmedyarova

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lazzat ZhussupbekovaDepartment of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan.
Alina BulatovaDepartment of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan.ORCID 0009-0002-3370-4584
Dinara NurkinaDepartment of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan.ORCID 0000-0002-3275-9682
Klara KurmangaliyevaDepartment of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan.
Venera RakhmetovaDepartment of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan.ORCID 0000-0001-5721-6409
Aigyul IzhanovaDepartment of Internal Medicine, Asfendiyarov Kazakh National Medical University Kazakhstan, Tole bi Street 94, Almaty 050000, Kazakhstan.
Kaergeldy MakhambetovDepartment of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan.
Elmira AkhmedyarovaDepartment of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decade, the growth of

Indexed as

antibiotic resistancedysbacteriosiseradication therapyHelicobacter pyloriintestinal microbiotaLactobacillusprobioticsSaccharomyces boulardii

Identifiers

PMID42193370
PMCPMC13203836

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.